共 50 条
The most relevant complications of transcatheter aortic valve implantation according to VARC criteria
被引:0
|作者:
Neragi-Miandoab, S.
[1
]
Salemi, A.
[2
]
机构:
[1] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Cardiovasc & Thorac Surg, New York, NY 10467 USA
[2] Cornell Univ, Med Ctr, Dept Cardiothorac Surg, New York, NY 10021 USA
来源:
关键词:
Aortic valve;
Cardiac surgical procedures;
complications;
Atrioventricular block;
ACUTE KIDNEY INJURY;
PERMANENT PACEMAKER IMPLANTATION;
ACCESS SITE COMPLICATIONS;
OUTCOME SOURCE REGISTRY;
END-POINT DEFINITIONS;
HIGH-RISK PATIENTS;
VASCULAR COMPLICATIONS;
BLOOD-TRANSFUSION;
CONSENSUS DOCUMENT;
EUROPEAN REGISTRY;
D O I:
暂无
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Transcatheter aortic valve implantation (TAVI) has been shown to be a viable alternative for high-risk patients who may not tolerate a surgi-. cal aortic valve replacement. The Edwards Sapien valve and the CoreValve are the most widely implanted valves worldwide. The indication may be expanded to intermediate and eventually low-risk patients in future; however, this will require a better understanding of potential complications and selecting the right valve for each individual patient. Although TAVI has expanded physicians' ability to intervene in many high-risk patients, there are still circumstances under which this procedure should not be considered, and some drawbacks have been identified, including important differences in periprocedural risks, aortic regurgitation, stroke, kidney injury, access associated complications, and significant conduction disturbances. One major concern is the higher rate of paravalvular leakage compared to SAVR. The Valve Academic Research Consortium established an independent collaboration between Academic Research organizations and specialty societies (cardiology and cardiac surgery) in the US and Europe. Consensus criteria were developed for the following endpoints: mortality, myocardial infarction, stroke, bleeding, acute kidney injury, vascular complications, and prosthetic valve performance. VARC definitions have already been incorporated into research and clinical practice. However, as clinical experience with this technology has matured and expanded, certain definitions have become unsuitable or ambiguous. The VARC 2 recommendations fry to define the following clinical endpoints: mortality, stroke, myocardial infarction, bleeding complications, acute kidney injury, vascular complications, conduction disturbances, and arrhythmias, as well as a miscellaneous category including relevant complications not otherwise categorized. This manuscript reviews the most relevant complications of TAVI-transapical and transfemoral.
引用
收藏
页码:205 / 220
页数:16
相关论文